Durham-based Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company . Founded in 2017, Vast Therapeutics is backed investors that include Cystic Fibrosis Foundation and Shionogi.
FOUNDED:
2017
INDUSTRY:
Biotechnology, Pharmaceutical
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
